Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Treatment for Ulcerative Colitis Flare Up | UCERIS (budesonide) Extended Release Tablets |
Description | If you've taken a steroid for your UC, then you may have experienced the side effects. Learn how UCERIS is different here at the official site. |
Keywords | Uceris, budesonide, ulcerative colitis flare up medication, ulcerative colitis treatment |
WebSite | www.uceris.com |
Host IP | 107.154.110.80 |
Location | United States |
Site | Rank |
salix.com | #2,250,124 |
ihaveuc.com | #3,612,760 |
cosmopharma.com | #3,120,421 |
uedem.net |
ufmedia.co.uk |
unifood.com.tr |
unimrcp.org |
unisal.br |
upaygoa.com |
upcanemis.com |
uriahtraining.com |
usps-track.us |
utf8-chartable.de |
skein.city |
skypeecs-prod-euw-0-b.cloudapp.net |
US$3,154
Last updated: Jan 14, 2020
Uceris.com has global traffic rank of 5,363,325. Uceris.com has an estimated worth of US$ 3,154, based on its estimated Ads revenue. Uceris.com receives approximately 576 unique visitors each day. Its web server is located in United States, with IP address 107.154.110.80. According to SiteAdvisor, uceris.com is safe to visit. |
Purchase/Sale Value | US$3,154 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$51 |
Yearly Ads Revenue | US$630 |
Daily Unique Visitors | 576 |
Note: All traffic and earnings values are estimates. |
Global Rank | 5,363,325 |
Delta (90 Days) | 0 |
Most Popular In Country | N/A |
Country Rank | N/A |
Host | Type | TTL | Data |
uceris.com | A | 21599 | IP: 107.154.110.80 |
uceris.com | A | 21599 | IP: 107.154.108.80 |
uceris.com | NS | 21599 | Target: ns2.markmonitor.com. |
uceris.com | NS | 21599 | Target: ns3.markmonitor.com. |
uceris.com | NS | 21599 | Target: ns4.markmonitor.com. |
uceris.com | NS | 21599 | Target: ns1.markmonitor.com. |
uceris.com | NS | 21599 | Target: ns5.markmonitor.com. |
uceris.com | NS | 21599 | Target: ns6.markmonitor.com. |
uceris.com | NS | 21599 | Target: ns7.markmonitor.com. |
uceris.com | TXT | 21599 | TXT: globalsign-domain-verification=H27Sf4xWzLLD5u9KfdGXV-Nq_dIsvnHXJpcUHLU6La |
uceris.com | TXT | 21599 | TXT: google-site-verification=EC0hf99GgOIUvn1f3FQqPzo8Fglqop1mhE-mxntxFUM |
uceris.com | SOA | 21599 | MNAME: ns1.markmonitor.com. RNAME: hostmaster.markmonitor.com. Serial: 2019043001 Refresh: 86400 Retry: 3600 Expire: 2592000 Minimum TTL: 172800 |
HTTP/1.1 301 Moved Permanently Location: https://www.uceris.com/ Content-Length: 0 Connection: close HTTP/1.1 200 OK Cache-Control: no-cache Pragma: no-cache Content-Type: text/html; charset=utf-8 Expires: -1 X-UA-Compatible: IE=edge Set-Cookie: dnn_IsMobile=False; path=/; HttpOnly Set-Cookie: language=en-US; path=/; HttpOnly Set-Cookie: .ASPXANONYMOUS=Q3lydfCmWW3I7G4_qVzbrqCu6mnqgTWeTS0_8bj6FEbnIHa3NxacvxXOerU-_4WJ57dGXUlJWUW5oB1b7zPfqCPSCB0jhyvlOWW4X-V9xHIf1OwP0; expires=Tue, 24-Mar-2020 05:40:48 GMT; path=/; HttpOnly Set-Cookie: Analytics_VisitorId=a1f7d36d-803c-4ea0-b354-50ce61f07e75; expires=Thu, 13-Feb-2020 19:00:48 GMT; path=/; HttpOnly Set-Cookie: Analytics=SessionId=814e7b3f-5db6-4a49-8754-065f09586192&TabId=8632&ContentItemId=-1; expires=Tue, 14-Jan-2020 20:00:48 GMT; path=/; HttpOnly Set-Cookie: __RequestVerificationToken=gudVoScsXeWp95ci6T9KuCN5HYymioyUJJKfkiFS7tGC16x0nOohQrtixRZJ2nx30VYn8g2; path=/; HttpOnly X-XSS-Protection: 1; mode=block X-Frame-Options: SAMEORIGIN Date: Tue, 14 Jan 2020 19:00:47 GMT Set-Cookie: visid_incap_820230=Wykx6rfpS/GDIKLwSvwSz98PHl4AAAAAQUIPAAAAAAD5Ado9QsWV/6z1JZLqS4XX; expires=Wed, 13 Jan 2021 06:36:19 GMT; path=/; Domain=.uceris.com Set-Cookie: nlbi_820230=14CCHFq5ERSpIa6UfcxRBQAAAADC4h5J8dAzJxxGxQtD8Xvn; path=/; Domain=.uceris.com Set-Cookie: incap_ses_1171_820230=Fm7XPGGzwR/lMlh/wjpAEN8PHl4AAAAAKE33ogYO+xfR/qpLWor65A==; path=/; Domain=.uceris.com Set-Cookie: ___utmvmiFBuVLBX=TxpNpeuPzBN; path=/; Max-Age=900 Set-Cookie: ___utmvaiFBuVLBX=zsMaXVn; path=/; Max-Age=900 Set-Cookie: ___utmvbiFBuVLBX=PZr XlXOAals: ftQ; path=/; Max-Age=900 X-CDN: Incapsula Transfer-Encoding: chunked X-Iinfo: 0-10255647-10255648 NNNN CT(21 65 0) RT(1579028447322 28) q(0 0 1 0) r(1 1) U12 |
Domain Name: UCERIS.COM Registry Domain ID: 1687349026_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2018-10-15T09:32:10Z Creation Date: 2011-11-15T21:28:24Z Registry Expiry Date: 2020-11-15T21:28:24Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ Domain Name: uceris.com Registry Domain ID: 1687349026_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2018-10-15T02:32:10-0700 Creation Date: 2011-11-15T13:28:24-0800 Registrar Registration Expiration Date: 2020-11-15T00:00:00-0800 Registrar: MarkMonitor, Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895770 Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited) Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited) Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited) Registrant Organization: Valeant Pharmaceuticals North America LLC Registrant State/Province: NJ Registrant Country: US Admin Organization: Valeant Pharmaceuticals North America LLC Admin State/Province: NJ Admin Country: US Tech Organization: Valeant Pharmaceuticals North America LLC Tech State/Province: NJ Tech Country: US Name Server: ns2.markmonitor.com Name Server: ns5.markmonitor.com Name Server: ns7.markmonitor.com Name Server: ns4.markmonitor.com Name Server: ns6.markmonitor.com Name Server: ns1.markmonitor.com Name Server: ns3.markmonitor.com DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ MarkMonitor is the Global Leader in Online Brand Protection. MarkMonitor Domain Management(TM) MarkMonitor Brand Protection(TM) MarkMonitor AntiCounterfeiting(TM) MarkMonitor AntiPiracy(TM) MarkMonitor AntiFraud(TM) Professional and Managed Services Visit MarkMonitor at https://www.markmonitor.com Contact us at +1.8007459229 In Europe, at +44.02032062220 |